ArticleJournal of nanobiotechnology2026
PD-L1-targeted OMV priming licenses myeloid co-stimulation and chemokine circuits to potentiate CAR-T therapy in advanced-stage solid tumors.
Yueyao Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.